No Data
Xi'An International Medical Investment (000516.SZ) has spent 57.427 million yuan to repurchase 10.9971 million shares.
Xi'An International Medical Investment (000516.SZ) issued an announcement that as of January 31, 2025, the company has accumulated through Shenzhen...
International Medicine: 2024 performance forecast
Xi'An International Medical Investment (000516.SZ): The proton therapy system is currently in the precision installation, debugging, and acceptance phase.
On January 3, Gelonghui reported that Xi'An International Medical Investment (000516.SZ) stated on the investor interactive platform that the Xi'An International Medical Investment is constructing a proton therapy center project. Currently, the proton therapy system has entered the precision installation, debugging, and acceptance phase, and it is expected to be completed and put into use by the end of 2025. Additionally, the company still has some land resources awaiting development. In the future, the company will further expand new business sectors such as life health management and integrated medical services based on the existing high-level Medical platform.
Xi'An International Medical Investment (000516.SZ): has cumulatively repurchased 0.49% of its shares.
On January 2, Glorious Group reported that Xi'An International Medical Investment (000516.SZ) announced that as of December 31, 2024, the company had cumulatively repurchased 10,997,100 shares through the Shenzhen Stock Exchange trading system via centralized bidding, accounting for 0.4865% of the company's current total share capital, with a maximum Fill Price of 5.618 yuan/share, a minimum Fill Price of 4.61 yuan/share, and a total transaction amount of 57.4268 million yuan (excluding transaction fees).
Xi'an international medical investment (000516.SZ): The maximum number of inpatient beds at Xi'an High-tech hospital has reached 1,680.
Gelonghui December 4th | Xi'an International Medical Investment (000516.SZ) stated in recent investor relations activities that recently, the maximum daily inpatient bed capacity of Xi'an Gaoxin Hospital has reached 1680 beds; the maximum daily inpatient bed capacity of the North and South campuses of Xi'an International Medical Investment Hospital has reached 3880 beds.
China Merchants Securities: Establishment of prepayment policy for medical insurance funds, releasing incremental signals at the bottom of the pharmaceutical sector.
It is reported that standardized prepayment process management, with the scale of regional prepayment in line with the approved standards for about one month, the prepayment system effectively alleviates the financial pressure of medical institutions, empowering the medical and pharmaceutical industry.
